Home
Conditions
Treatments
Trials
Explore
🏠
/
treatments
/
SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥1 and <10 years
/
mega-study
SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥1 and <10 years